PH KOREA 2026

Program

Full Program June 26 (Fri.), 2026 June 27 (Sat.), 2026
Session P1 Room P (4F) EASOPH Session
Chairs Wook-Jin Chung (President of KSPH, Korea)
Keiko Yamauchi-Takihara (Osaka Univ., Japan)
June 26 (Fri.)
09:00-10:40		 09:00-09:25 SP1-1 TBD
Stephan Rosenkranz (Univ. of Cologne, Germany)
09:25-09:45 SP1-2 Taiwan
Chih-Hsin Hsu (National Cheng Kung Univ., Taiwan)
09:45-10:05 SP1-3 PH management in Japan
Yoshihiro Fukumoto (Kurume Univ. School of Medicine, Japan)
10:05-10:25 SP1-4 China
Zhi-Cheng Jing (Guangdong Cardiovascular Institute, China)
10:25-10:40 Panel Discussion
Jae-Hyeong Park (Chungnam National Univ., Korea)
Hwa Jin Cho (Chonnam National Univ., Korea)
Sung-Hee Shin (Inha Univ., Korea)
Session H1 Room H (4F) Basic Research Session: What's Been Found from Basic PH Research? Korean
Chairs 김종민 (숙명여자대학교 생명시스템학부)
김원호 (국립보건연구원 만성질환융복합연구부 부장)
June 26 (Fri.)
09:00-10:40		 09:00-09:30 SH1-1 Bioengineered Pulmonary Microvessels to Decode Mechanobiology in PAH: Translating Vascular Forces into Therapeutic Targets
Samuel G. Rayner (Univ. of Washington, USA)
09:30-09:50 SH1-2 scMultiome Analysis Identifies a Key Driver for Pulmonary Hypertension
진석원 (광주과학기술원 생명과학과)
09:50-10:10 SH1-3 Personalized Disease Modeling of Pulmonary Hypertension Using a Multi Organ Platform from Patient-derived iPSCs
박진규 (한림대학교 의학과)
10:10-10:40 Panel Discussion
최효인 (성균관의대 순환기내과)
정세용 (연세의대 소아심장과)
Takahiro Hiraide (Keio Univ. School of Medicine, Japan)
하현수 (연세의대 심장내과)
Session P2 Room P (4F) Keynote Lecture for PH: Cutting Edge Treatment Strategies
Chairs Nick H. Kim (UCSD, USA)
Kye Hun Kim (Chonnam National Univ., Korea)
June 26 (Fri.)
11:00-12:40		 11:00-11:20 SP2-1 Beyond the Numbers: Diagnostic Precision and Biological Endotypes in Pulmonary Arterial Hypertension
Samuel G. Rayner (Univ. of Washington, USA)
11:20-11:40 SP2-2 Treatment Goals for PAH
Hiromi Matsubara (Okayama Medical Center, Japan)
11:40-12:00 SP2-3 PAH with cardiopulmonary comorbidities: Importance of patient-specific treatment goal
Takahiro Hiraide (Keio Univ. School of Medicine, Japan)
12:00-12:20 SP2-4 TBD
Stephan Rosenkranz (Univ. of Cologne, Germany)
12:20-12:40 Panel Discussion
Sung-Hee Shin (Inha Univ., Korea)
Jung Hyun Choi (Pusan National Univ., Korea)
Chan Hong Jeon (Soonchunhyang Univ., Korea)
Session H2 Room H (4F) Hot Issues and Recent Progress of PH Care in Each Field
Chairs Hyuk-Jae Chang (Yonsei Univ., Korea)
John Feenstra (The Wesley Hospital, Australia)
June 26 (Fri.)
11:00-12:40		 11:00-11:20 SH2-1 Experience with Sotatercept in pediatric‑onset IPAH
Shigetoyo Kogaki (Osaka General Medical Center, Japan)
11:20-11:40 SH2-2 Adult cardiology
Dae-Hee Kim (Ulsan Univ., Korea)
11:40-12:00 SH2-3 Pulmonology
Hang Jea Jang (Inje Univ., Korea)
12:00-12:20 SH2-4 Hot issues and recent progress of Pulmonary Hypertension care in Connective Tissue Diseases
Jae Hyun Jung (Korea Univ., Korea)
12:20-12:40 Panel Discussion
Ji-Hun Jang (Inha Univ., Korea)
Kee Soo Ha (Korea Univ., Korea)
Yeon-Ah Lee (Kyung Hee Univ., Korea)
Session S1 Room S (4F) PHOENIKS Sessions, for the Next Stage Korean
Chairs 김원호 (국립보건연구원 만성질환융복합연구부 부장)
정욱진 (가천의대 심장내과)
June 26 (Fri.)
11:00-12:20		 11:00-11:20 SS1-1 PHOENIKS 3기 연구 결과 및 4기 PHOENIKS
하경은 (가천의대 심장내과)
11:20-11:40 SS1-2 CTEPH
안철민 (연세의대 심장내과)
11:40-12:00 SS1-3 Multi-Omics in Pulmonary Arterial Hypertension: Progress, Pitfalls, and the Role of the PHOENIKS Biobank
김성식 (가천의대 내과)
12:00-12:20 Panel Discussion
임현정 (국립보건연구원 심혈관질환연구과 과장)
김종민 (숙명여대 생명시스템학부)
하현수 (연세의대 심장내과)
박진규 (한림의대 의학과)
진석원 (광주과학기술원 생명과학과)
Luncheon Session 1 Room P (4F) Johnson&Johnson
Chairs Jowon Jung (Yonsei Univ., Korea)
Jang-Won Son (Yeungnam Univ.)
June 26 (Fri.)
12:40-13:20		 12:40-13:00 L1-1 The Role of OPSYNVI® in PAH treatment goals : From Early risk reduction to Sustained low‑risk status
Dae-Hee Kim (Ulsan Univ., Korea)
13:00-13:20 L1-2 Clinical Efficacy of OPSYNVI® Compared with Monotherapy : Clinical evidence and Real-world practice in PAH
Jung Hyun Choi (Pusan National Univ., Korea)
Luncheon Session 2 Room H (4F) Bayer Korean
Chairs 이신석 (전남의대 류마티스내과)
최재영 (연세의대 소아심장과)
June 26 (Fri.)
12:40-13:20		 12:40-13:00 L2-1 Unlocking the potential of PAH management w/ Riociguat
손정우 (연세의대 심장내과)
13:00-13:20 L2-2 Establishing CTEPH standard of care
이재승 (울산의대 호흡기내과)
Session P3 Room P (4F) Global PH Summit: About Overcoming Treatment Hurdles in the World
Chairs Wook-Jin Chung (President of KSPH, Korea)
Yoshihiro Fukumoto (President of JPCPHS, Japan)
June 26 (Fri.)
13:30-15:10		 13:30-13:50 SP3-1 TBD
John Feenstra (The Wesley Hospital, Australia)
13:50-14:10 SP3-2 RNF213 R4810K: Asian-specific poor prognostic factor and its underlying mechanism
Takahiro Hiraide (Keio Univ. School of Medicine, Japan)
14:10-14:30 SP3-3 Challenges and Opportunities for Non-PAH PH
Chih-Hsin Hsu (National Cheng Kung Univ., Taiwan)
14:30-14:50 SP3-4 TBD
Ju-Hee Lee (Chungbuk National Univ., Korea)
14:50-15:10 Panel Discussion
Taeil Yang (Gachon Univ., Korea)
Seung Min Baek (Seoul National Univ., Korea)
Ji-Hun Jang (Inha Univ., Korea)
Kang Un Choi (Yeungnam Univ., Korea)
Session H3 Room H (4F) Pulmonary Hypertension Means to Me Korean
Chairs 이신석 (전남의대 류마티스내과)
박용범 (한림의대 호흡기내과)
June 26 (Fri.)
13:30-15:10		 13:30-13:45 SH3-1 adult cardiologist, interventionist
Hiromi Matsubara (NHO Okayama Medical Center, Japan)
13:45-14:00 SH3-2 adult cardiologist, image specialist
최정현 (부산의대 순환기내과)
14:00-14:15 SH3-3 pediatric cardiologist
송진영 (성균관의대 소아청소년과)
14:15-14:30 SH3-4 A Pulmonologist's Perspective
이재승 (울산의대 호흡기내과)
14:30-14:45 SH3-5 A Rheumatologist’s Perspective
전찬홍 (순천향의대 류마티스내과)
14:45-15:00 SH3-6 A Thoracic Surgeon's Perspective
박샘이나 (서울의대 심장혈관흉부외과)
15:00-15:10 Panel Discussion
서혜선 (이화의대 순환기내과)
김정윤 (부천세종병원 소아청소년과)
손정우 (연세의대 심장내과)
Session S2 Room S (4F) Best Oral Presentation
(10 min presentation + 5 min Q&A)
Chairs Shigetoyo Kogaki (Osaka General Medical Center, Japan)
Sung Kee Ryu (Ewha Womans Univ., Korea)
June 26 (Fri.)
13:30-14:45		 13:30-13:45 SS2-1 Automated CT-Derived Pulmonary Artery Enlargement Reflects Hemodynamic Burden in Pulmonary Hypertension
Taehwa Kim (Kosin University Gaspel Hospital, Korea)
13:45-14:00 SS2-2 Inhaled Nitric Oxide via High-Flow Nasal Cannula in Post-Repair Congenital Heart Disease Patients with Pulmonary Hypertension After Extubation: A Cohort Study with Propensity Score Matching
Xiaofeng Wang (National Center for Cardiovascular Disease and Fuwai Hospital, China)
14:00-14:15 SS2-3 Real-World Outcomes of Pulmonary Hypertension in the Era of Advanced Therapies in a Tertiary Children’s Hospital
Kyung Suk Lee (Hanyang University Guri Hospital, Korea)
14:15-14:30 SS2-4 Circulating DKK1 Is Linked to Pulmonary Vascular Remodeling and Increased Pulmonary Artery Pressure in Early-Stage Non-Small Cell Lung Cancer
Xu Mengxin (Shandong University, China)
14:30-14:45 SS2-5 Pulmonary Arterial Hypertension–Targeted Therapy Followed by Partial Closure in Patients With Congenital Shunt Lesions and Eisenmenger Physiology
Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
Panels Hye Won Kwon (Seoul National Univ., Korea)
Hee Dong Kim (Soonchunhyang Univ., Korea)
Kyung Min Ko (Catholic Kwandong Univ., Korea)
Session P4 Room P (4F) Young Investigator Award
(10 min presentation + 5 min Q&A)
Chairs Chih-Hsin Hsu (National Cheng Kung Univ., Taiwan)
Kook Yang Park (Gachon Univ., Korea)
June 26 (Fri.)
15:30-16:45		 15:30-15:45 SP4-1 Single-Nucleus Profiling Identifies PDGFD+ Fibroblast Subpopulations as Key Drivers of Right Ventricular Remodeling in Pulmonary Arterial Hypertension
Yang Fang (Shanghai Children's Medical Center, China)
15:45-16:00 SP4-2 Clinical–Hemodynamic Discordance and Long-Term Outcomes in Pulmonary Arterial Hypertension: Findings from the PHOENIKS Longitudinal Cohort
Sang Hoon Park (Gachon University Gil Medical Center, Korea)
16:00-16:15 SP4-3 CXCL6 promotes pulmonary hypertension by activating pulmonary artery smooth muscle cells
Yi Yan (Shanghai Children's Medical Center, China)
16:15-16:30 SP4-4 Plasma proteomics of Korean IPAH patients suggests potential biomarkers that correlates with mPAP and PVR, further suggesting new insights into pathobiology of PAH
Sungseek Kim (Gachon University, Korea)
Panels Sanghyun Lee (Pusan National Univ., Korea)
Ala Woo (Yonsei Univ., Korea)
Sujin Moon (The Catholic Univ. of Korea, Korea)
Ji Seok Bang (Bucheon Sejong Hospital, Korea)
Session H4 Room H (4F) Special Lecture Korean
Chair 정욱진 (대한폐고혈압학회 회장)
June 26 (Fri.)
15:30-16:00		 15:30-16:00 SH4-1 VTB-10 for new PAH specific drug
강상원 (이화여대 생명공학과)
Session P5 Room P (4F) All Images about PH
Chairs Hae-Ok Jung (The Catholic Univ. of Korea, Korea)
Hojoong Kim (Eulji Univ., Korea)
Shozaburo Doi (Institute of Science Tokyo, Japan)
June 26 (Fri.)
16:55-18:30		 16:55-17:15 SP5-1 Echocardiography
Kye Hun Kim (Chonnam National Univ., Korea)
17:15-17:35 SP5-2 Nuclear medicine for the diagnosis and treatment response evaluation of pulmonary hypertension
Young Seok Cho (Sungkyunkwan Univ., Korea)
17:35-17:55 SP5-3 CT and MRI in pulmonary hypertension
Young Jin Kim (Yonsei Univ., Korea)
17:55-18:15 SP5-4 Pathology
Eun Na Kim (Seoul National Univ., Korea)
18:15-18:30 Panel Discussion
Hoon Ko (Pusan National Univ., Korea)
In-Cheol Kim (Keimyung Univ., Korea)
Sung-Hee Shin (Inha Univ., Korea)
Soo Yong Lee (Pusan National Univ., Korea)
Kyung Eun Ha (Gachon Univ., Korea)
Session H6 Room H (4F) 정책 세션: Finding Solutions about Unsolved Problems in the Field of Pulmonary Hypertension Korean
Chairs 조명찬 (충북의대 심장내과)
박재형 (충남의대 심장내과)
June 26 (Fri.)
16:55-18:30		 16:55-17:15 SH6-1 Problems about treating pediatric patients with pulmonary hypertension
김기범 (서울의대 소아청소년과)
17:15-17:35 SH6-2 What we want to support from the government?
윤영진 (폐동맥고혈압환우회 회장)
17:35-17:55 SH6-3 Unsolved problem in pulmonary hypertension
장항제 (인제의대 호흡기내과)
17:55-18:15 SH6-4 어떻게 하면 희귀질환에서 사용가능한 약제를 보험화할 수 있나?
이숙현 (심사평가원 신약등재부)
18:15-18:30 Panel Discussion
최선 (메디칼타임즈 기자)
이진한 (동아일보 의학전문기자)
김봉준 (고신의대 심장내과)
정진향 (중증희귀질환연합회 사무총장)
안상호 (한국선천성심장병환우회 대표)
Morning Session 1 Room P (4F) Samjin Pharm. Korean
Chairs 정성환 (가천의대 호흡기알레르기내과)
정조원 (연세의대 소아심장과)
June 27 (Sat.)
08:20-09:00		 08:20-09:00 M1-1 Evolving RWE: Long-Term Clinical Benefits and Adherence Optimization with Maciten
김인철 (계명의대 심장내과)
Session P6 Room P (4F) Joint Session with Korean Society of Echocardiography
Chairs Seok Min Kang (Yonsei Univ., Korea)
Kye Hun Kim (Chonnam National Univ., Korea)
June 27 (Sat.)
09:00-10:40		 09:00-09:20 SP6-1 Echo-based Screening and Probability Assessment in Pulmonary Hypertension
Ran Heo (Hanyang Univ., Korea)
09:20-09:40 SP6-2 Integration of Echo and RHC: Bridging the Gap in Clinical Practice
Jino Park (Inje Univ., Korea)
09:40-10:00 SP6-3 Right heart function and Right Ventricular–Pulmonary Arterial Coupling in Pulmonary Hypertension
Jae-Hyeong Park (Chungnam National Univ., Korea)
10:00-10:20 SP6-4 Exercise induced PH: Clinical Significance and Diagnostic Pitfalls
Seonhwa Lee (Yonsei Univ., Korea)
10:20-10:40 Panel Discussion
Jung-Won Lee (Yonsei Univ., Korea)
Hee Dong Kim (Soonchunhyang Univ., Korea)
Hee Jeong Lee (Keimyung Univ., Korea)
Mi-Hyang Jung (The Catholic Univ. of Korea, Korea)
Seung Min Baek (Seoul National Univ., Korea)
Session H7 Room H (4F) Multidisciplinary Team Approach for Pulmonary Hypertension Korean
Chairs 이형두 (부산의대 소아청소년과)
박용범 (한림의대 호흡기내과)
June 27 (Sat.)
09:00-10:40		 09:00-09:15 SH7-1 PH specialist
김대희 (울산의대 심장내과)
09:15-09:30 SH7-2 Cardiac Rehabilitation for Pulmonary Hypertension
유제현 (가천의대 재활의학과)
09:30-09:45 SH7-3 Cardiac Surgeon in Multidisciplinary Team for Pulmonary Hypertension
김호진 (울산의대 심장혈관흉부외과)
09:45-10:00 SH7-4 Psychiatric Symptoms and Treatment Considerations in Patients with Pulmonary Hypertension
조서은 (가천의대 정신건강의학과)
10:00-10:15 SH7-5 폐동맥고혈압 환자의 사회복지제도 활용
오봉근 (아우름케어메니지먼트 대표이사)
10:15-10:30 SH7-6 Multidisciplinary Team Approach for Pulmonary Hypertension: The Role of the Specialist Nurse in the AMC PHT Center
김영숙 (서울아산병원 코디네이터)
10:30-10:40 Panel Discussion
박지명 (서울의대 호흡기내과)
정세용 (연세의대 소아심장과)
조동혁 (고려의대 순환기내과)
정현주 (한양의대 심장내과)
Session S3 Room S (4F) Early Career PH Scientist Case Korean
(7 min presentation + 8 min Q&A)
Chairs 장항제 (인제의대 호흡기내과)
정혜문 (경희의대 심장내과)
June 27 (Sat.)
10:00-11:15		 10:00-10:15 SS3-1 Dyspnea in SSc-ILD: Acute exacerbation or Occult pulmonary vascular disease?
고경민 (가톨릭관동의대 류마티스내과)
10:15-10:30 SS3-2 Therapeutic Decision-Making in an Adult Patient with Patent Ductus Arteriosus, Pulmonary Hypertension, and Concomitant Left-Sided Heart Disease: A Case Report
박상훈 (가천의대 심장내과)
10:30-10:45 SS3-3 Pulmonary Hypertension in a Young Adult with an Atypical Cystic Fibrosis Phenotype
이덕우 (서울의대 소아청소년과)
10:45-11:00 SS3-4 PAWP in 'Zone of Uncertainty': Group 2 Pulmonary Hypertension Mimicking Pre-capillary PH Following Diuretic Therapy
김채은 (가천의대 내과)
11:00-11:15 SS3-5 Timing of evaluation and treatment for CTD-PAH: A 39-years old female case
김희동 (순천향의대 심장내과)
Panles 김기범 (서울의대 소아청소년과)
최정현 (부산의대 순환기내과)
이상재 (고려대학교의료원교류협력대자인병원 순환기내과)
이상현 (부산의대 순환기내과)
Session P7 Room P (4F) New Disease Modifying Drugs for PH
Chairs Wook-Jin Chung (Gachon Univ., Korea)
Zhi-Cheng Jing (Guangdong Cardiovascular Institute, China)
June 27 (Sat.)
10:50-12:10		 10:50-11:10 SP7-1 Treprostinil Palmitil Inhalation Powder as a Treatment for PAH
Hiromi Matsubara (NHO Okayama Medical Center, Japan)
11:10-11:30 SP7-2 TBD
John Feenstra (The Wesley Hospital, Australia)
11:30-11:50 SP7-3 Ralinepag for the treatment of pulmonary arterial hypertension: results of the ADVANCE Outcomes study
Derek Solum (United Therapeutics, USA)
11:50-12:10 Panel Discussion
In Hyun Jung (Yonsei Univ., Korea)
In-Cheol Kim (Keimyung Univ., Korea)
Uram Jin (Ajou Univ., Korea)
Kee Soo Ha (Korea Univ., Korea)
Session H8 Room H (4F) Joint Session with Korean Society of Heart Failure (KSHF), Navigating the Complexity of PH-LHD: From Hemodynamic Assessment to Targeted Strategy Korean
Chairs 유병수 (연세의대 심장내과)
강석민 (연세의대 심장내과)
June 27 (Sat.)
10:50-12:10		 10:50-11:05 SH8-1 Hemodynamic Phenotypes of Group 2 PH: Isolated vs Combined Post-Capillary PH
손정우 (연세의대 심장내과)
11:05-11:20 SH8-2 The Forgotten Ventricle in Left Heart Disease: RV-PA Coupling
윤종찬 (가톨릭의대 순환기내과)
11:20-11:35 SH8-3 The Metabolic Phenotype: Obesity, Inflammation, and HFpEF-PH
김경희 (인천세종병원 심장내과)
11:35-11:50 SH8-4 Therapeutic Dilemmas: Is there a role for PAH-specific vasodilators
정혜문 (경희의대 심장내과)
11:50-12:10 Panel Discussion
박진주 (서울의대 심장내과)
이수용 (부산의대 순환기내과)
안효석 (가톨릭의대 순환기내과)
Session P8 Room P (4F) Presidential Lecture and Plenary Lectures
Chairs Kye Hun Kim (Chonnam National Univ., Korea)
Keiko Yamauchi-Takihara (Osaka Univ., Japan)
June 27 (Sat.)
12:10-13:10		 12:10-12:30 PH8-1 Future Perspectives for Overcoming Pulmonary Hypertension
Wook-Jin Chung (President of KSPH, Korea)
12:30-12:50 PH8-2 Lessons from negative PH trials
Nick H. Kim (UCSD, USA)
12:50-13:10 PH8-3 Real World of patients with CHD-PH in Japan: Insights from the Japanese Association of CHD-PH Registry (JACPHR) study approved by JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT (AMED)
Shozaburo Doi (Institute of Science Tokyo, Japan)
Luncheon Session 3 Room P (4F) MSD
Chairs Namsik Chung (PHILMEDIS CLINICS, Korea)
Seok Min Kang (Yonsei Univ., Korea)
June 27 (Sat.)
13:10-13:50		 13:10-13:30 L3-1 The First Activin Signal Inhibitor, Sotatercept
Jung Hyun Choi (Pusan National Univ., Korea)
13:30-13:50 L3-2 Learnings from Real World Experience of Sotatercept
Nick H. Kim (UCSD, USA)
Luncheon Session 4 Room H (4F) Celltrion Pharm.&Chong Kun Dang Korean
Chairs 신익균 (가천의대 심장내과)
유병수 (연세의대 심장내과)
June 27 (Sat.)
13:10-13:50		 13:10-13:30 L4-1 Beta blocker use in Hypertension : Old & New Sight
정중화 (조선의대 순환기내과)
13:30-13:50 L4-2 How is Carvedilol different from other beta blockers : β-blockers & Beyond
김경희 (인천세종병원 심장내과)
Session P9 Room P (4F) Partners Session: All About Activin Signaling Inhibitor
Chairs Wook-Jin Chung (Gachon Univ., Korea)
Hiromi Matsubara (NHO Okayama Medical Center, Japan)
June 27 (Sat.)
14:10-15:50		 14:10-14:30 SP9-1 Sotatercept for Patients Not Reaching Low Risk
Dae-Hee Kim (Ulsan Univ., Korea)
14:30-14:50 SP9-2 Paradigm Shift in PAH Treatment and Role of Sotatercept
John Feenstra (The Wesley Hospital, Australia)
14:50-15:10 SP9-3 Sotatercept Position in Guidelines and How Does It Really Work
Soo Yong Lee (Pusan National Univ., Korea)
15:10-15:30 SP9-4 Who Would Benefit from ASI / Sotatercept in Korea? (Deep dive into CTD-PAH)
Jina Yeo (Gachon Univ., Korea)
15:30-15:50 Panel Discussion
Minjae Yoon (Seoul National Univ., Korea)
Uram Jin (Ajou Univ., Korea)
Hyo-In Choi (Sungkyunkwan Univ., Korea)
Sung Hae Chang (Korea Univ., Korea)
Session H9 Room H (4F) 개원의 및 전공의 교육 I Korean
Chairs 정조원 (연세의대 소아심장과)
이은봉 (서울의대 류마티스내과)
June 27 (Sat.)
14:10-15:50		 14:10-14:30 SH9-1 폐고혈압의 정의 및 분류
나진오 (고려의대 순환기내과)
14:30-14:50 SH9-2 폐고혈압의 우심도자술 및 심초음파 소견
황석재 (검단탑병원 심장내과)
14:50-15:10 SH9-3 폐고혈압 진단시 폐질환 및 CTEPH의 감별
장항제 (인제의대 호흡기내과)
15:10-15:30 SH9-4 폐동맥 고혈압 진단시 류마티스질환 감별
이연아 (경희의대 류마티스내과)
15:30-15:50 Panel Discussion
정혜문 (경희의대 심장내과)
김소리 (고려의대 순환기내과)
표정윤 (서울의대 류마티스내과)
김송이 (연세의대 호흡기내과)
양태일 (가천의대 심장내과)
Session S4 Room S (4F) Case Competition Session
(10 min presentation + 5 min Q&A)
Chairs Hyun-Sook Kim (Soonchunhyang Univ., Korea)
Eui-Young Choi (Yonsei Univ., Korea)
June 27 (Sat.)
14:10-15:25		 14:10-14:25 SS4-1 Long-term management in a specific CHD-PAH patient who ultimately needed lung transplantation
Duck Woo Lee (Seoul National University Hospital, Korea)
14:25-14:40 SS4-2 The Great Impostor:Severe Pulmonary Stenosis Presenting as Refractory Pulmonary Hypertension
Chi-Yao Huang (Taichung Veterans General Hospital, Taiwan)
14:40-14:55 SS4-3 Long-term stabilization after PAH-targeted therapy and partial closure in elderly women with PDA-associated pulmonary arterial hypertension and Eisenmenger physiology: a two-case educational report
Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
14:55-15:10 SS4-4 Hemoptysis in Pulmonary Arterial Hypertension: The Challenge of a Rare Origin of The Anomalous Systemic Artery
I-Hsin Tsi (China Medical University Children's Hospital, Taiwan)
15:10-15:25 SS4-5 Sotatercept as Add-on Quadruple Therapy in Progressive CTD-Associated Pulmonary Arterial Hypertension Despite Prostacyclin-Based Triple Therapy: A Case Report
Sungseek Kim (Gachon University, Korea)
Panels Juyang Jung (Ajou Univ., Korea)
Sun Hwa Lee (Jeonbuk National Univ., Korea)
Sung Uk Kwon (Inje Univ., Korea)
Ja-Kyoung Yoon (Sungkyunkwan Univ., Korea)
Session P10 Room P (4F) Right Heart Journal Session: It's Right Time to Start RHJ!
Chairs Wook-Jin Chung (E-i-C, RHJ, Korea)
Nick H. Kim (UCSD, USA)
June 27 (Sat.)
16:00-17:40		 16:00-16:20 SP10-1 Why we need 'RHJ'? From EASOPH's perspectives
Hiromi Matsubara (Okayama Medical Center, Japan)
16:20-16:40 SP10-2 Why we need 'RHJ'? From Global perspectives
Stephan Rosenkranz (Univ. of Cologne, Germany)
16:40-17:00 SP10-3 How do we develop 'RHJ' to the top soon? From EASOPH's perspectives
Chih-Hsin Hsu (National Cheng Kung Univ., Taiwan)
17:00-17:20 SP10-4 How do we Deliver RHJ to the Top? A Global Perspective
Samuel G. Rayner (Univ. of Washington, USA)
17:20-17:40 Panel Discussion
Kye Hun Kim (Chonnam National Univ., Korea)
Jin-Oh Na (Korea Univ., Korea)
Hyun-Jin Kim (Hanyang Univ., Korea)
Session H10 Room H (4F) 개원의 및 전공의 교육 II Korean
Chairs 정혜문 (경희의대 심장내과)
박재형 (충남의대 심장내과)
June 27 (Sat.)
16:00-17:30		 16:00-16:20 SH10-1 가이드라인에 입각한 risk assessment 및 치료 알고리듬
김경희 (인천세종병원 심장내과)
16:20-16:40 SH10-2 폐고혈압 치료 약제 소개 (1) ERA, PDE, sGC stimulators
김봉준 (고신의대 심장내과)
16:40-17:00 SH10-3 폐고혈압 치료 약제 소개 (2) prostacyclin receptor agonist, sotatercept
최정현 (부산의대 순환기내과)
17:00-17:20 SH10-4 간질환에 의한 폐동맥고혈압 치료
김대희 (울산의대 심장내과)
17:20-17:30 Panel Discussion
박성미 (고려의대 심장내과)
소문승 (아주의대 순환기내과)
박우영 (서울의대 소아심장분과)
이상현 (부산의대 순환기내과)
박상훈 (가천의대 심장내과)